DE1795544A1 - METHOD FOR PRODUCING PHENYLAMINO-PYRIDINES - Google Patents

METHOD FOR PRODUCING PHENYLAMINO-PYRIDINES

Info

Publication number
DE1795544A1
DE1795544A1 DE19641795544 DE1795544A DE1795544A1 DE 1795544 A1 DE1795544 A1 DE 1795544A1 DE 19641795544 DE19641795544 DE 19641795544 DE 1795544 A DE1795544 A DE 1795544A DE 1795544 A1 DE1795544 A1 DE 1795544A1
Authority
DE
Germany
Prior art keywords
groups
nitro
edema
group
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19641795544
Other languages
German (de)
Inventor
Walter Von Dr Bebenburg
Guenter Dr Steinmetz
Kurt Dr Thiele
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evonik Operations GmbH
Original Assignee
Degussa GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa GmbH filed Critical Degussa GmbH
Priority to DE19641795544 priority Critical patent/DE1795544A1/en
Publication of DE1795544A1 publication Critical patent/DE1795544A1/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals

Description

Verfahren zur Herstellung von Phenylamino-pyridinen Ausseheidullg aus Patent (Anmeldung P 14 45 673.6-D 45302) Die Erfindung betrifft ein Verfahren zur Herstellung von neuen Verbindungen der allgemeinen Formel I worin ltj Wasserstoff, eine Aminogruppe oder eine Alkylaminogruppe ist und die Reste n2 und R3 gleich oder verschieden sind und Halogenatome, Trifluormethylgruppen, niedriginolekulare Alkoxygruppen, Hydroxygruppen, Carboxygruppen oder Aminogruppen bedeuten und deren Salze.Process for the production of phenylamino-pyridines Ausseheidullg from patent (application P 14 45 673.6-D 45302) The invention relates to a process for the production of new compounds of the general formula I. where ltj is hydrogen, an amino group or an alkylamino group and the radicals n2 and R3 are identical or different and are halogen atoms, trifluoromethyl groups, low molecular weight alkoxy groups, hydroxyl groups, carboxy groups or amino groups and their salts.

Die neuen Verbindugen haben wertvolle pharmakologische Eigenschaften. Sie zeichnen sich durch eine hohe antiphlogistische Wirkung aus.The new compounds have valuable pharmacological properties. They are characterized by a high anti-inflammatory effect.

Die Herstellung der erfindungsgemäßen Verbindungen erfolgt dadurch, daß man in an sich bekannter Weise in einer Verbindung der allgemeinen Formell II worin R1, R2 und R3 die umseitig angegebenen Bedeutungen haben, außerdem auch noch Nitrogruppen sein könne, diese Nitrogruppe(n) nach bekannten Methoden, vorzugsweise in Gegenwart eines Katalysators beispielsweise flaney-Nickel reduziert.The compounds according to the invention are prepared by reacting in a manner known per se in a compound of the general formula II where R1, R2 and R3 have the meanings given overleaf, and can also be nitro groups, this nitro group (s) reduced by known methods, preferably in the presence of a catalyst, for example flaney nickel.

Es empfiehlt sich, die nydrierung der Nitrogruppen bei etwa 70° C und bei einem Druck von etwa 20 bis 30 atü durchzuführen.It is advisable to hydrogenate the nitro groups at around 70 ° C and to be carried out at a pressure of about 20 to 30 atmospheres.

Außer llaney-Nickel können noch folgende Katalysatoren verwendet werden: Palladium-Mohr oder Palladium oder Palladiumhydroxyd auf Trägermaterial wie Bariumsulfat oder Calciumcarbonat. Die Reduktion kann auch mit Zink/Salzsäure, Zinn/Salzsäure, Zinn (II) chlorid/Salzsäure oder Eisen/Salzsäure oder Salzen des Schwefelwasserstoffs in Alkohol/Wasser bei etwa 700 bis etwa 1200 C oder mit aktiviertem Aluminium in wasserhaltigem Äther bei 200 bis 40° C durchgeführt werden.In addition to llaney nickel, the following catalysts can also be used: Palladium black or palladium or palladium hydroxide on a carrier material such as barium sulfate or calcium carbonate. The reduction can also be carried out with zinc / hydrochloric acid, tin / hydrochloric acid, Tin (II) chloride / hydrochloric acid or iron / hydrochloric acid or salts of hydrogen sulfide in alcohol / water at about 700 to about 1200 C or with activated aluminum in water-containing ether at 200 to 40 ° C.

Di» erfindungsgemäßen Verbindungen können in an sich bekannter Weise in die Salze übergeführt werden.The compounds according to the invention can be used in a manner known per se be converted into the salts.

Beispiel 1 2-(3-Trifluoromethylphenylamino)-5-amino-pyridin 142 g 2-(3-Trifluoromethylphenylamino)-5-nitro-pyridin werden in 600 ml Methanol in Gegenwart von 30 g Raney-Nickel bei 700 C und 20 bis 30 atü hydriert. Nach dem Abdampfen des Lösungsmittels wird der Rückstand im Vakuum destilliert. Die Base geht bei 0,5 Torr bei 190 bis 1920 C über. Sie bildet mit Maleinsäure ein kristallines Salz, das nach dem Umkristallisieren aus Isopropanol bei 115° C schmilzt.Example 1 2- (3-Trifluoromethylphenylamino) -5-aminopyridine 142 g of 2- (3-trifluoromethylphenylamino) -5-nitro-pyridine are hydrogenated in 600 ml of methanol in the presence of 30 g of Raney nickel at 700 ° C. and 20 to 30 atmospheres. After the solvent has evaporated, the residue is distilled in vacuo. The base goes over at 0.5 torr at 190 to 1920.degree. It forms a crystalline salt with maleic acid, which melts at 115 ° C after recrystallization from isopropanol.

Beispiel 2 2-(4-Pentylexyphenylamino )-5-amino-pyridin 2-(4-Pentyloxyphenylamino)-5-nitro-pyridin wird analog Reispiel i mit Raney-Nickel hydriert und aufgearbeitet. Die Base siedet bei 0,5 Torr zwischen 225 und 2350 C.Example 2 2- (4-pentylexyphenylamino) -5-aminopyridine 2- (4-Pentyloxyphenylamino) -5-nitro-pyridine is hydrogenated with Raney nickel and worked up analogously to Example i. The base boils at 0.5 torr between 225 and 2350 C.

Beispiel 3 2-(4-Fluor-phenylamino)-5-amino-pyridin 126 g 2-(4-Fluor-phenylamino)-5-nitro-pyridin werden in 1,2 1 Methanol aufgeschlemmt und in Gegenwart von 13 g Raney-Nickel bei 600 C und 50 atü Druck im Autoklaven hydriert. Nach Absaugen des Katalysators wird das Filtrat eingedampft und der Riickstand aus Alkohol/Benzin umkristallisiert, F. 141° C.Example 3 2- (4-fluoro-phenylamino) -5-aminopyridine 126 g of 2- (4-fluoro-phenylamino) -5-nitro-pyridine are suspended in 1.2 l of methanol and hydrogenated in the presence of 13 g of Raney nickel at 600 ° C. and 50 atmospheric pressure in an autoclave. After the catalyst has been filtered off with suction, the filtrate is evaporated and the residue is recrystallized from alcohol / gasoline, mp 141 ° C.

Beispiel 4 2-(2-Methyl-5-chlor-phenylamino)-5-amino-pyridin Man reduziert 2-(2-Methyl-5-chlor-phenylamino)-5-nitro-pyridin wie in Beispiel 3 . Das Reaktionsprodukt wird im Vakuum destilliert.Example 4 2- (2-Methyl-5-chlorophenylamino) -5-aminopyridine 2- (2-Methyl-5-chlorophenylamino) -5-nitro-pyridine is reduced as in Example 3. The reaction product is distilled in vacuo.

Kp. 0,5: 190 - 5° C; Ausbeute: 92 %.Bp 0.5: 190-5 ° C; Yield: 92%.

Beispiel 5 2, 3-Diamino-6-(3-trifluormethyl-phenyl-amino)-pyridin 115 g (0,5 Mol) 2-Amino-3-nitro-6-(3-trifluoromethyl-phenyl amino)-pyridin in 500 ml Dioxan wird mit 12 g Pd/Aktivkohle (10%) unter Zusatz von 60 g Natriumsulfat bei 20 atu und 500 C hydriert. Nach dem Absaugen setzt man 100 ml Äther und nenzin bis zur beginnenden Trübung zu. Die Base kristallisiert aus.Example 5 2,3-Diamino-6- (3-trifluoromethyl-phenyl-amino) -pyridine 115 g (0.5 mol) of 2-amino-3-nitro-6- (3-trifluoromethyl-phenylamino) -pyridine in 500 ml of dioxane is mixed with 12 g of Pd / activated carbon (10%) with the addition of 60 g of sodium sulfate Hydrogenated at 20 atu and 500C. After suctioning off, add 100 ml of ether and benzine until the onset of cloudiness. The base crystallizes out.

Sie wird rasch abgesaugt (luftempfindlich). Ausbeute: 70 g.It is quickly sucked off (sensitive to air). Yield: 70 g.

Durch Zusatz von isopropanolischer Salzsäure zu einer Lösung des Amins in Äthanol fäll @ das Ilydroclilorid aus.By adding isopropanolic hydrochloric acid to a solution of the amine Ilydroclilorid precipitates in ethanol.

Fp. 30(30 C (zers.).M.p. 30 (30 C (dec.).

Beispiel 6 2, 3-Diamino-6-(2, 3-diclllorpllenyl)-aminoyridin Eine Lösung von 27 g 2-Amino-3-nitro-6-(2,3-dichlorphenyl)-aminopyridin in 400 g Dioxan wird wie in Beispiel 3 hydriert.Example 6 2,3-Diamino-6- (2,3-dicllloropllenyl) -aminoyridine A solution of 27 g of 2-amino-3-nitro-6- (2,3-dichlorophenyl) aminopyridine in 400 g of dioxane is hydrogenated as in Example 3.

Zu der filtrierten Hydrierlösung fügt man 100 ml 6 N isopropanolische HCl. Das ausgefallene Salz wird abgesaugt und aus Methanol umkristallisiert.100 ml of 6N isopropanolic are added to the filtered hydrogenation solution HCl. The precipitated salt is filtered off with suction and recrystallized from methanol.

F. 257 - 90 (z).F. 257-90 (z).

Claims (2)

P a t e ii t a n s p r ü c h e 1. Verfahren zur erstellung von Verbindungen der allgemeinen Formel I worin R1 Wasserstoff, eine Aminogruppe oder eine Alkylaminogruppe ist und die Reste R2 und R3 gleich oder verschieden sind und Halogenatome, Trifluormethylgruppen, niedrigmolekulare Alkoxygruppen, Hydroxygruppen, Carboxygruppen oder Aminogruppen bedeuten, dadurch gekennzeichnet, daß man in an sich bekannter Weise in einer Verbindung der allgemeinen Formel II worin R1, R2 und R3 die oben angegebenen Bedeutungen haben, außerdem auch noch Nitrogruppen sein kennen, diese Nltrogruppe(n) nach bekannten Methoden, vorzugsweise in Gegenwart eines Katalysators beispielsweise Raney-Nickel reduziert.P ate ii claims 1. Process for the preparation of compounds of the general formula I where R1 is hydrogen, an amino group or an alkylamino group and the radicals R2 and R3 are identical or different and mean halogen atoms, trifluoromethyl groups, low molecular weight alkoxy groups, hydroxyl groups, carboxy groups or amino groups, characterized in that in a manner known per se in a compound of the general Formula II in which R1, R2 and R3 have the meanings given above, and also know to be nitro groups, these nitro group (s) are reduced by known methods, preferably in the presence of a catalyst, for example Raney nickel. 2. Verfahren nach Anspruch i, dadurch gekennzeichnet, daß man die erhaltenen Verbindungen in die Salze überführt.2. The method according to claim i, characterized in that the The compounds obtained are converted into the salts. Anlage zu Ausscheidung aus P 14 45 673.6-44 (D 45 302) Versuchshericht Die erfindungsgemäßen Verbindungen wurden am Eiweißödem der Rattenpfote nach der Methode von DMENJOZ und mitarb., Arch. exp. Pharm.Path. 230, 325 (1957) auf antiphlogistische Wirkung geprüft. Die antipholgistische Wirkung ist als Ödemhemmung in Prozent gegenüber der unbehandelten Kontrollgruppe angegeben.Annex to excretion from P 14 45 673.6-44 (D 45 302) test report The compounds according to the invention were on protein edema of the rat paw after Method by DMENJOZ and colleagues, Arch. Exp. Pharm.Path. 230, 325 (1957) on anti-inflammatory Effect tested. The antipholgistic effect is as opposed to edema inhibition in percent the untreated control group. Es wurde bei sämtlichen Versuchen oral appliziert. Die Dosis war stets 300 mg/kg Ratte.It was applied orally in all experiments. The dose was always 300 mg / kg rat. Die Toxizitätsprüfung wurde an der Maus oral durch Bestimmung der akuten Toxizität (LD 50 mg/kg) nach Miller und Tainter (Proc.Soc.Exper.Biol.and Med. 57, 261 (1944) durchgeführt.The toxicity test was carried out on the mouse orally by determining the acute toxicity (LD 50 mg / kg) according to Miller and Tainter (Proc.Soc.Exper.Biol.and Med. 57, 261 (1944). Die Beobachtungszeit betrug 24 Stunden.The observation time was 24 hours. Als Vergleichssubstanz wurde das bekannte nntiphlogistilium Phenylbutazon gewählt. Die Ergebnisse sind in der folgenden Tabelle enthalten.The well-known anti-inflammatory phenylbutazone was used as a comparison substance chosen. The results are given in the table below. Substanz Eiweiß-Ödem LD 50 mg/kg Hemmung in % oral Beispiel bei 300 mg/kg oral 1 51 1 130 6 40 4 000 Phenyl-35 530 butazonSubstance protein edema LD 50 mg / kg inhibition in% oral example at 300 mg / kg oral 1 51 1 130 6 40 4 000 phenyl-35 530 butazone
DE19641795544 1964-08-29 1964-08-29 METHOD FOR PRODUCING PHENYLAMINO-PYRIDINES Pending DE1795544A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19641795544 DE1795544A1 (en) 1964-08-29 1964-08-29 METHOD FOR PRODUCING PHENYLAMINO-PYRIDINES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19641795544 DE1795544A1 (en) 1964-08-29 1964-08-29 METHOD FOR PRODUCING PHENYLAMINO-PYRIDINES

Publications (1)

Publication Number Publication Date
DE1795544A1 true DE1795544A1 (en) 1973-02-15

Family

ID=5708205

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19641795544 Pending DE1795544A1 (en) 1964-08-29 1964-08-29 METHOD FOR PRODUCING PHENYLAMINO-PYRIDINES

Country Status (1)

Country Link
DE (1) DE1795544A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0424848A2 (en) * 1989-10-24 1991-05-02 Hoechst-Roussel Pharmaceuticals Incorporated Aminopyridinylaminophenols and related compounds, a process and intermediates for their preparation and their use as medicaments

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0424848A2 (en) * 1989-10-24 1991-05-02 Hoechst-Roussel Pharmaceuticals Incorporated Aminopyridinylaminophenols and related compounds, a process and intermediates for their preparation and their use as medicaments
EP0424848A3 (en) * 1989-10-24 1991-10-02 Hoechst-Roussel Pharmaceuticals Incorporated Aminopyridinylaminophenols and related compounds, a process and intermediates for their preparation and their use as medicaments

Similar Documents

Publication Publication Date Title
DE3132882A1 (en) NEW PIPERAZINONE, THEIR PRODUCTION AND USE
DE1670522A1 (en) Process for the production of new substituted aminopyridines
DE819093C (en) Process for the production of thyroxine and its derivatives
DE1445904A1 (en) Process for the preparation of 4-imidazolidone compounds
DE1226115B (en) Process for the preparation of new amino-halogen-benzylamines
DE2413102A1 (en) PROCESS FOR THE PRODUCTION OF 1- (3,5DIHYDROXYPHENYL) -1-HYDROXY-2-SQUARE CLIP ON 1-METHYL-2- (4-HYDROXYPHENYL) -AETHYL SQUARE CLIP FOR -AMINO-ETHANE
DE1795544A1 (en) METHOD FOR PRODUCING PHENYLAMINO-PYRIDINES
DE1251770B (en) Process for the production of aliphatic hydroxydiamines and their acid addition salts
CH624104A5 (en)
DE953256C (en) Process for the preparation of therapeutically active bis-[ª‰-(o-oxyphenyl)-isopropyl]-amines
DE946058C (en) Process for the preparation of 3-aminoindanes
DE1195762B (en) Process for the preparation of new naphthalene-1, 4, 5, 8-tetracarboxylic acid diimides
DE1018869B (en) Process for the preparation of aminoalkyl purine derivatives
DE1235929B (en) Process for the preparation of 2- (2'-pyrazinyl) benzimidazole and its salts
AT267527B (en) Process for the preparation of new substituted aminopyridines, their salts and optically active isomers
AT247353B (en) Process for the preparation of new 2-chloro-4-azaphenthiazine derivatives
DE954155C (en) Process for the preparation of 4-aminochromans
DE1795180C3 (en) Benzylaminopyridines
AT250338B (en) Process for the preparation of new, basic derivatives of substituted benzofuran-2-carboxylic acids and their salts
AT347473B (en) PROCESS FOR THE PREPARATION OF NEW MORPHOLINE COMPOUNDS AND THEIR NON-TOXIC SALT
DE1695757C3 (en) Pyridine methanol carbamates and processes for their preparation
DE1078122B (en) Process for the preparation of 1-cyclohexylaminoindanes and -aminohydrindanes
DE1445673C (en) Phenylamino pyridines
DE946540C (en) Process for the preparation of alkylated dioxopiperidines
DE837097C (en) Process for the preparation of new pyrimidine compounds